Adherence to guidelines across different specialties to prevent infections in patients undergoing immunosuppressive therapies

Table 1 Specialty and general guidelines used for audit outcomes

Specialty	Society or other organisation guideline	Infection prevention items recommended^a	Reference
Dermatology	British Association of Dermatology [Methotrexate], 2016	2–5, 7, 8	[12]
Dermatology	British Association of Dermatology [Biologics], 2017	2–5, 7, 8	[13]
Gastroenterology	European Cohn’s & Colitis Organisation [2014]	2, 7, 8	[8]
Gastroenterology	British Society of Gastroenterology [2011]	2, 7, 8	[9]
Haematology	British Society of Haematology [DLB Lymphoma] 2016	3	[11]
Nephrology	British Transplant Society	2–5, 7, 8	[10]
Rheumatology	European League against Rheumatism [DMARDs and vaccines], 2011 & 2016	7	[14, 15]
Rheumatology	British Society of Rheumatology [DMARD & psoriatic arthropathy] 2017	7	[16]
Other guidelines [for consensus guidelines]	UK Green Book [vaccinations]	7	[17]
Other guidelines [for consensus guidelines]	NICE Blood-borne virus screening	3	[18, 19]

^aItems: 1. Discussion with patient around general risks of infections; 2. Screening for active or latent tuberculosis [TB]; 3. Screening for Hepatitis B & C and HIV infection, including previous hepatitis B exposure and immunity; 4. Screening for varicella immunity; 5. Screening for measles immunity; 6. Screening for hypogammaglobulinaemia; 7. Recommendation of influenza, pneumococcal, +/− other indicated vaccines; 8. Provision of P. jiroveci prophylaxis

ISSN: 1471-2334